SEC INSIDER TRANSACTIONS

Moderna, Inc. (MRNA) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

MRNA · Moderna, Inc.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 32 filings · fetched 2026-11-13T18:57:57Z

Recent reported activity

0purchase rows on this page

1sale rows on this page

130matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-05-15Filed 2026-05-18	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. F2 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F3 This option is fully vested and exercisable. References: F1, F3	M Exercise / conversionStock Option (Right to Buy) · Derivative	16,110D	0	Direct	Form 4 ↗0001682852-26-000103
2026-05-15Filed 2026-05-18	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. F2 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F3 This option is fully vested and exercisable. References: F1, F3	M Exercise / conversionStock Option (Right to Buy) · Derivative	37,226D	0	Direct	Form 4 ↗0001682852-26-000103
2026-05-15Filed 2026-05-18	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. F2 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F3 This option is fully vested and exercisable. References: F1	S Sale (market/private)Common Stock · Non-derivative	53,336D	48.4	Direct	Form 4 ↗0001682852-26-000103
2026-05-15Filed 2026-05-18	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. F2 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F3 This option is fully vested and exercisable. References: F1	M Exercise / conversionCommon Stock · Non-derivative	16,110A	19.15	Direct	Form 4 ↗0001682852-26-000103
2026-05-15Filed 2026-05-18	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. F2 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F3 This option is fully vested and exercisable. References: F1	M Exercise / conversionCommon Stock · Non-derivative	37,226A	19.15	Direct	Form 4 ↗0001682852-26-000103

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.